Correlation Between Foghorn Therapeutics and Inventiva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Inventiva Sa, you can compare the effects of market volatilities on Foghorn Therapeutics and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Inventiva.

Diversification Opportunities for Foghorn Therapeutics and Inventiva

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Foghorn and Inventiva is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Inventiva go up and down completely randomly.

Pair Corralation between Foghorn Therapeutics and Inventiva

Given the investment horizon of 90 days Foghorn Therapeutics is expected to under-perform the Inventiva. In addition to that, Foghorn Therapeutics is 2.01 times more volatile than Inventiva Sa. It trades about -0.06 of its total potential returns per unit of risk. Inventiva Sa is currently generating about -0.05 per unit of volatility. If you would invest  271.00  in Inventiva Sa on August 29, 2024 and sell it today you would lose (7.00) from holding Inventiva Sa or give up 2.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Foghorn Therapeutics  vs.  Inventiva Sa

 Performance 
       Timeline  
Foghorn Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Foghorn Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Foghorn Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Inventiva Sa 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inventiva Sa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Inventiva sustained solid returns over the last few months and may actually be approaching a breakup point.

Foghorn Therapeutics and Inventiva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Foghorn Therapeutics and Inventiva

The main advantage of trading using opposite Foghorn Therapeutics and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.
The idea behind Foghorn Therapeutics and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope